Navigation Links
Spray on contraceptive clears Phase I trial

An Australian drug delivery company called Acrux specializes in administering medicines// through the skin. It has recently reported positive results for its Phase I clinical results of a contraceptive for women in the form of a spray.

The novel contraceptive spray called Nestorone MDTS is being developed in collaboration with a US-based research group 'The Population Council'. Interestingly the Phase I pharmacokinetic study showed that once-a-day dosing of the contraceptive spray Nestorone MDTS provided sustained delivery of the contraceptive agent.

Nestorone is a fourth-generation progestin is well tolerated, with no serious adverse events. A once a day application delivers consistent amounts through the skin to the blood stream. The contraceptive skin spray has the potential advantages of not having to be taken at exactly the same time each day and being suitable for breast-feeding mothers, according to Acrux, which also said the system has reduced skin irritation compared to patches.

The transdermal delivery system for drugs is a big market worth over $3 billion a year in the US alone and is growing at a rapid pace.

The transdermal delivery of drugs has some distinct advantages over oral or intravenous dosing of drugs. It avoids issues such as gastric irritability due to changes in pH that occur with oral dosing and variable transit times in the gut resulting in rapid fluctuations in plasma concentrations.
'"/>




Page: 1

Related medicine news :

1. Nasal Spray Could Take Drugs Direct to Brain.
2. Nasal Spray Could Take Drugs Directly to Brain
3. Nasal Spray Beats Antihistamine
4. Relief For British MS Patients: Cannabis-Based Oral Spray
5. Beware Of Bogus Claims by HGH Spray Internet Marketers
6. Spray-on skin: Effective in Relieving Stress of Child Burn Victims
7. Cluster Headaches Can Be Treated By Nasal Spray
8. Quick –fix Solution: Spray-on a Condom
9. Much Ado About Herbicide Sprays?
10. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
11. TEMPE Spray Delays Ejaculation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: